Means ± SD (N=9-12 rats for all parameters)
Different from Controls: *P<0.001; †P=0.005; ‡P< 0.02;
Different from Diabetics: §P<0.02; lIP=0.05 [25]
|
| Figure 2: Effects of the SDI-CP-166,572 (200 mg/kg bwt/day) and the ARI
Sorbinil (50 mg/kg bwt/day) on distal tibial MNCV and on sciatic nerve NADH/
NAD+c and NADH/NAD+ m in rats with diabetes of 18 weeks duration. Means ± SD (N=9-12 rats for all parameters) Different from Controls: *P<0.001; †P=0.005; ‡P< 0.02; Different from Diabetics: §P<0.02; lIP=0.05 [25] |
